摘要
摘要: 背景:压力通过多种机制参与记忆障碍,包括激活下丘脑 - 垂体轴,从而激活血液中皮质酮的释放。胆碱能系统被毒蕈碱拮抗剂,东莨菪碱阻断也会损害记忆。 目的:本研究旨在探讨姜黄素(20mg / kg)对胆碱能阻滞小鼠应激模型学习记忆和胆碱能系统的影响。 方法:使用东莨菪碱在小鼠中诱导限制性应激并阻断胆碱能受体。用姜黄(也进行NMR分析的姜黄根粉末)处理动物,并研究学习和社会行为。姜黄素对胆碱能毒蕈碱受体(mAChR; M1,M3和M5)基因表达的影响通过RT-PCR在前额叶皮质和海马前两者中进行评估。 结果:姜黄素,姜黄素和α-亚麻酸是姜黄提取物中的铅化合物。与对照组相比,应激小鼠观察到血清皮质酮水平升高,而姜黄治疗显着降低血清皮质酮水平。在强调动物的莫里斯水迷宫测试中,姜黄治疗引起了学习和记忆的改善。在姜黄治疗的动物中也恢复了社会新奇性。姜黄治疗后,M5表达在皮层改善,M3表达在应激+东莨菪碱+姜黄治疗组海马中有改善。 结论:这些发现通过增加M3,M5的表达,改善学习和记忆,突出了姜黄的治疗作用。姜黄可以成为治疗由压力引起的遗忘症的有效候选者。
关键词: 皮质酮,社会行为,胆碱能系统,东莨菪碱,姜黄。
图形摘要
Current Drug Targets
Title:Pharmacological Effects of Turmeric on Learning, Memory and Expression of Muscarinic Receptor Genes (M1, M3 and M5) in Stress-induced Mouse Model
Volume: 18 Issue: 13
关键词: 皮质酮,社会行为,胆碱能系统,东莨菪碱,姜黄。
摘要: Abstract: Background: Stress is involved in memory impairment through multiple mechanisms, including activation of hypothalamic-pituitary axis, which in turn activates release of corticosterone in blood. Cholinergic system blockade by the muscarinic antagonist, scopolamine, also impairs memory.
Objective: This study aimed to investigate the effect of turmeric (20mg/kg) on learning and memory and cholinergic system in a mouse model of stress along with cholinergic blockade. Methods: Restrained stress was induced and cholinergic receptors were blocked using scopolamine in mice. Animals were treated with turmeric (turmeric rhizome powder which was also subjected to NMR analyses) and learning and social behavior was examined. Effect of turmeric on cholinergic muscarinic receptors (mAChR; M1, M3 and M5) gene expression was assessed by RT-PCR in both pre-frontal cortex and hippocampus. Results: Ar-turmerone, curcuminoids and α-linolenic acid were the lead compounds present in turmeric extract. Increased serum corticosterone levels were observed in stressed mice when compared to the control group, while turmeric treatment significantly reduced serum corticosterone level. Turmeric treatment caused an improved learning and memory in Morris water maze test in stressed animals. Social novelty preference was also restored in turmeric treated animals. Following turmeric treatment, M5 expression was improved in the cortex and M3 expression was improved in the hippocampus of stress + scopolamine + turmeric treated group. Conclusions: These findings highlight the therapeutic role of turmeric by increasing the expression of M3, M5 and improving learning and memory. Turmeric can be an effective candidate for the treatment of amnesia caused by the stress.Export Options
About this article
Cite this article as:
Pharmacological Effects of Turmeric on Learning, Memory and Expression of Muscarinic Receptor Genes (M1, M3 and M5) in Stress-induced Mouse Model, Current Drug Targets 2017; 18 (13) . https://dx.doi.org/10.2174/1389450118666170315120627
DOI https://dx.doi.org/10.2174/1389450118666170315120627 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent on Biomarkers in Medical Research: A Focus on Neuropsychiatric Disorders
Recent Patents on Biomarkers Delirium in Older Patients – A Review
Current Psychiatry Reviews Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia
Current Pharmaceutical Design Genetic Variations of the Hemostatic System as Risk Factors for Venous and Arterial Thrombotic Disease
Current Genomics N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer’s Disease Therapy
Current Alzheimer Research Analysis of Copy Number Variation in Alzheimer’s Disease: The NIALOAD/ NCRAD Family Study
Current Alzheimer Research Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Current Pharmaceutical Design Comparative Evaluation of Ethanolic Extracts of Bacopa monnieri, Evolvulus alsinoides, Tinospora cordifolia and their Combinations on Cognitive Functions in Rats
Current Aging Science Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Introduction: Strategies, Molecular Targets and Animal Models Useful for Developing Therapies for Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Plasma Clusterin as a Potential Biomarker for Alzheimer’s Disease-A Systematic Review and Meta-analysis
Current Alzheimer Research Antiplatelet Therapy and Oral Anticoagulation for Prevention of Ischemic Stroke
Current Drug Therapy Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
CNS & Neurological Disorders - Drug Targets Alzheimer Biomarkers and Clinical Alzheimer Disease were Not Associated with Increased Cerebrovascular Disease in a Memory Clinic Population
Current Alzheimer Research Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design Generation of Alzheimer’s Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor
Current Alzheimer Research The Interactions Between Alzheimer’s Disease and Major Depression: Role of Ca<sup>2+</sup> Channel Blockers and Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Molecular Docking Study of a Series of Substituted Xanthone Derivatives as Novel COX-2 Inhibitors Targeting Prostaglandin Endoperoxide Synthase -2
Current Enzyme Inhibition Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents Interactions Between Plasma Proteins and Naturally Occurring Polyphenols
Current Drug Metabolism